Active, not recruitingPhase 3NCT02716233

A French Protocol for the Treatment of Acute Lymphoblastic Leukemia (ALL) in Children and Adolescents

Studying PAPA syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Assistance Publique - Hôpitaux de Paris
Intervention
pegaspargase 1250 IU/m2 x 2(drug)
Enrollment
2044 target
Eligibility
18 years · All sexes
Timeline
20162027

Study locations (28)

Collaborators

Shire

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02716233 on ClinicalTrials.gov

Other trials for PAPA syndrome

Additional recruiting or active studies for the same condition.

See all trials for PAPA syndrome

← Back to all trials